Mode
Text Size
Log in / Sign up
Phase 4 N=114 Randomized Triple-blind Treatment

Gabapentin as an Adjunct to Paracervical Block for Perioperative Pain Management

Pain

Enrolled (actual)
114
Serious AEs
0.0%
Results posted
Aug 2019
Primary outcome: Primary: Pain at Time of Uterine Evacuation — 63.79; 62.21; 64.58; 66.12 score on a scale

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Gabapentin (Drug); Placebo (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
Emory University
Primary completion
Jun 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Pain at Time of Uterine Evacuation
63.79; 62.21; 64.58; 66.12; 67.77; 71.06
SECONDARY
Perioperative Pain Level
20.76; 22.48; 44.10; 47.61; 30.64; 43.68
SECONDARY
Number of Participants Using Pain Medication
24; 27
SECONDARY
Perioperative Nausea
26; 26; 1; 12; 0; 5
SECONDARY
Perioperative Vomiting
4; 7; 5; 2; 5; 5
SECONDARY
Anxiety Levels
66; 72; 14; 17; 4; 2
SECONDARY
Side Effects
27; 23; 19; 15; 9; 9
SECONDARY
Moderate Pain at Postoperation Follow-up Assessment
5.2; 5.2
SECONDARY
Severe Pain at Postoperation Follow-up Assessment
3.5; 3.2
SECONDARY
Nausea or Vomiting at Postoperation Follow-up Assessment
2.3; 3.2
SECONDARY
Vomiting Since Leaving Clinic
46; 45; 1; 2
SECONDARY
Overall Satisfaction With the Procedure
0; 1; 0; 0; 0; 2

Summary

This is a randomized controlled trial of gabapentin 600 mg compared to placebo given 1-2 hours preoperatively in conjunction with perioperative paracervical block for surgical abortion. The researchers hypothesize that adding gabapentin to local anesthesia will reduce perioperative and postoperative pain associated with surgical abortion. Additionally, the researchers hypothesize that gabapentin will reduce nausea, vomiting, anxiety, and consumption of pain medication.

Eligibility Criteria

Inclusion Criteria

  • Women >=18 years-old
  • Presenting for a surgical abortion
  • Fluency in English and able to provide informed consent
  • Has a driver to take them home following the procedure

Exclusion Criteria

  • Allergy, sensitivity or contraindication to gabapentin
  • Severe renal disease
  • Currently using gabapentin or pregabalin
  • Contraindication to outpatient abortion under local anesthesia
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02944656). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search